bs-75635C [Life Science]
Merafloxacin
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Formulation Solid

Storage: Stable for 2 years after receipt when stored at -20°C.

Product Information:

CAS Number: 110013-21-3

Molecular formula: C19H23F2N3O3

Molecular weight: 379.4

Purity: >98% (NMR)

Appearance: White to off-white solid.

Solubility: Soluble in DMSO.

InChiKey: BAYYCLWCHFVRLV-UHFFFAOYSA-N

SMILES: O=C1C2=CC(F)=C(N3CCC(CNCC)C3)C(F)=C2N(CC)C=C1C(O)=O

Description:

Merafloxacin is a fluoroquinolone broad-spectrum antibacterial compound. It is an inhibitor of bacterial DNA gyrase and Type II DNA topoisomerase. It demonstrated excellent activity against Gram-positive organisms and less potent activity against Gram-negative bacteria. Merafloxacin is a programmed -1 ribosomal frameshifting (-1 PRF) inhibitor of SARS-CoV-2. Frameshift inhibition by merafloxacin is robust to mutations within the pseudoknot region and is similarly effective on -1 PRF of other betacoronaviruses and blocks SARS-CoV-2 replication in Vero E6 cells. The compound reduced viral levels in infected African green monkey VeroE6 cells in a concentration-dependent manner. Merafloxacin showed no cellular toxicity and resulted in a 3 to 4 orders of magnitude reduction of SARS-CoV-2 titer, with IC50 of 4.3 µMu. This compound provides a starting point for high-throughput screening for frameshifting inhibitors as a viable target for therapeutic intervention against SARS-CoV-2.

Size: 5mg,25mg,

Applications: Life Science()

For research use only. Not intended for diagnostic or therapeutic use.